Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study

Technology in Cancer Research and Treatment

Volumn 7, Issue 6, 2008, Pages 441-447

  Adkison, Jarrod B ^a   Khuntia, Deepak ^a   Bentzen, Søren M ^a   Cannon, George M ^a   Tome, Wolfgang A ^a   Jaradat, Hazim ^a   Walker, Wendy ^a   Traynor, Anne M ^a   Weigel, Tracey ^a   Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Dose escalation; Hypofractionation; Image guided radiotherapy; IMRT; Tomotherapy

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MALE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; TOMOTHERAPY; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 57749169285     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460800700605     Document Type: Article

References (18)

1. Perez, C. A., Stanley, K., Rubin, P., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45, 2744-2753 (1980).
2. Kong, F. M., Ten Haken, R. K., Schipper, M. J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63, 324-333 (2005).
3. Belderbos, J. S., Heemsbergen, W. D., De Jaeger, K., et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66, 126-134 (2006).
4. Yuan, S., Sun, X., Li, M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30, 239-244 (2007).
5. Yom, S. S., Liao, Z., Liu, H. H., et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68, 94-102 (2007).
6. Sura, S., Gupta, V., Yorke, E., et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol 87, 17-23 (2008).
7. Horiot, J. C., Bontemps, P., van den Bogaert, W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44, 111-121 (1997).
8. Fu, K. K., Pajak, T. F., Trotti, A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48, 7-16 (2000).
9. Saunders, M., Dische, S., Barrett, A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 52, 137-148 (1999).
10. Giraud, P., Antoine, M., Larrouy, A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48, 1015-1024 (2000).
11. Boswell, S., Tome, W., Jeraj, R., et al. Automatic registration of megavoltage to kilovoltage CT images in helical tomotherapy: an evaluation of the setup verification process for the special case of a rigid head phantom. Med Phys 33, 4395-4404 (2006).
12. Kwa, S. L., Lebesque, J. V., Theuws, J. C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42, 1-9 (1998).
13. Mountain, C. F. Revisions in the International System for Staging Lung Cancer. Chest 111, 1710-1717 (1997).
14. Bradley, J., Graham, M. V., Winter, K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable nonsmall-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61, 318-328 (2005).
15. Rosenzweig, K. E., Sura, S., Jackson, A., et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25, 5557-5561 (2007).
16. Rosenzweig, K. E., Fox, J. L., Yorke, E., et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103, 2118-2127 (2005).
17. Kong, F. M., Hayman, J. A., Griffith, K. A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65, 1075-1086 (2006).
18. Hayman, J. A., Martel, M. K., Ten Haken, R. K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19, 127-136 (2001).